These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12410704)

  • 1. An immunohistochemical and ultrastructural study of syringocystadenoma papilliferum.
    Yamamoto O; Doi Y; Hamada T; Hisaoka M; Sasaguri Y
    Br J Dermatol; 2002 Nov; 147(5):936-45. PubMed ID: 12410704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical study of the apocrine type of cutaneous mixed tumors with special reference to their follicular and sebaceous differentiation.
    Yamamoto O; Yasuda H
    J Cutan Pathol; 1999 May; 26(5):232-41. PubMed ID: 10408348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical and ultrastructural observations of desmoplastic trichoepithelioma with a special reference to a morphological comparison with normal apocrine acrosyringeum.
    Yamamoto O; Hamada T; Doi Y; Sasaguri Y; Hashimoto H
    J Cutan Pathol; 2002 Jan; 29(1):15-26. PubMed ID: 11841513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of keratin proteins in sweat gland tumours by the use of monoclonal antibody.
    Noda Y; Kumasa S; Higashiyama H; Mori M
    Pathol Res Pract; 1988 Jun; 183(3):284-91. PubMed ID: 2458577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation.
    Misago N; Narisawa Y
    J Dermatol; 2006 Jan; 33(1):2-9. PubMed ID: 16469077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors.
    Eckert F; de Viragh PA; Schmid U
    J Cutan Pathol; 1994 Apr; 21(2):140-50. PubMed ID: 7518849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vimentin expression in sweat gland tumours.
    Huang JW; Kunikata M; Hashimura K; Sakamoto F; Ogata K; Mori M; Yoneda K; Yanagihara M; Mori S
    Acta Histochem; 1992; 93(2):402-10. PubMed ID: 1337643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoepithelial differentiation in benign sweat gland tumors. Demonstrated by a monoclonal antibody to alpha-smooth muscle actin.
    Eckert F; Betke M; Schmoeckel C; Neuweiler J; Schmid U
    J Cutan Pathol; 1992 Aug; 19(4):294-301. PubMed ID: 1331211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringocystadenoma papilliferum on the male nipple.
    Shindo M; Yamada N; Yoshida Y; Yamamoto O; Morino S
    J Dermatol; 2011 Jun; 38(6):593-6. PubMed ID: 21914158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of cytokeratin polypeptides in syringomas. An immunohistochemical study on paraffin-embedded material.
    Eckert F; Nilles M; Schmid U; Altmannsberger M
    Am J Dermatopathol; 1992 Apr; 14(2):115-21. PubMed ID: 1373584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin expression of apocrine and eccrine poromas with special reference to its expression in cuticular cells.
    Yamamoto O; Hisaoka M; Yasuda H; Kasai T; Hashimoto H
    J Cutan Pathol; 2000 Aug; 27(7):367-73. PubMed ID: 10917164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 distribution in sweat gland tumors suggests it has different functional roles in the various cell types.
    Fernández-Figueras MT; Puig L; Ariza A; Calatrava A; Fuente MJ; Ferrándiz C
    Am J Dermatopathol; 1996 Oct; 18(5):483-9. PubMed ID: 8902095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of ductal sweat gland carcinoma connected to syringocystadenoma papilliferum arising in nevus sebaceus.
    Ansai S; Koseki S; Hashimoto H; Hozumi Y; Kondo S
    J Cutan Pathol; 1994 Dec; 21(6):557-63. PubMed ID: 7699123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
    Parks A; Branch KD; Metcalf J; Underwood P; Young J
    Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical differentiation of four benign eccrine tumors.
    Missall TA; Burkemper NM; Jensen SL; Hurley MY
    J Cutan Pathol; 2009 Feb; 36(2):190-6. PubMed ID: 18564284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands].
    Blind A; Weingertner N; Cribier B
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogenesis and possible mechanism of chondroid changes in mixed tumour of the skin: immunohistochemical evaluation of bone morphogenetic protein, glycosaminoglycans, keratin, vimentin and neuronal markers.
    Mori M; Shrestha P; Sakamoto F; Yang LJ; Qin C; Tsujimura T
    Arch Dermatol Res; 1994; 286(5):285-92. PubMed ID: 7520226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
    Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
    J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of cytokeratin expression in apocrine cystadenoma or hidrocystoma.
    Ohnishi T; Watanabe S
    J Cutan Pathol; 1999 Jul; 26(6):295-300. PubMed ID: 10472758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma.
    Yamamoto O; Asahi M
    Br J Dermatol; 1999 Jan; 140(1):8-16. PubMed ID: 10215762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.